Disease-free survival, comparing patients with or without a donor, among patients with a normal karyotype and NPM1⁺/Flt3-ITD^−.
 Reproduced with permission from Schlenk RF, Dohner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1909–1918.¹⁹